APGE returns by year
Apogee Therapeutics Inc. has returned +83.2% annually (CAGR) since 2024. Calendar-year, monthly and weekly total returns for Apogee Therapeutics Inc. (APGE) below, through August 13, 2026 — the most recent year is year-to-date.
Apogee Therapeutics Inc. returns by year (2024–2026)#
Calendar-year returns with each year's path and its dividend contribution (dividend return = total minus price return).
| Year | Start price | End price | Path | Dividend | Total return |
|---|---|---|---|---|---|
| 2026YTD | $75.48 | $134.42 | +0.0% | +78.1% | |
| 2025 | $45.30 | $75.48 | +0.0% | +66.6% | |
| 2024 | $27.94 | $45.30 | +0.0% | +62.1% |
Total return by period
Methodology#
Returns are total returns (dividends reinvested), computed from APGE's split- and dividend-adjusted closes. The bar chart switches between annual and monthly periods. Annualized return is the compound annual growth rate over the full period. The current year is year-to-date. See also the periodic table of returns. Past performance does not predict future returns; not investment advice.
See also: S&P 500 · Nasdaq-100 · Dow Jones · Russell 2000 · US Bond Market · Gold · Silver · Bitcoin · Ethereum
FAQ#
- What is Apogee Therapeutics Inc.'s average annual return?
- Since 2024, Apogee Therapeutics Inc. (APGE) has returned about 83.2% a year (the compound annual growth rate) and an average calendar-year return of 64.4%.
- What were Apogee Therapeutics Inc.'s best and worst years?
- Over 2024–2026, the best year was 2025 (+66.6%) and the worst was 2024 (+62.1%).
- How often is Apogee Therapeutics Inc. up in a year?
- 2 of the 2 full years since 2024 were positive — about 100% of the time.